Literature DB >> 20140002

Differential binding of bispyridinium oxime drugs with acetylcholinesterase.

Manoj K Kesharwani1, Bishwajit Ganguly, Amit Das, Tusar Bandyopadhyay.   

Abstract

AIM: To performe a time-dependent topographical delineation of protein-drug interactions to gain molecular insight into the supremacy of Ortho-7 over HI-6 in reactivating tabun-conjugated mouse acetylcholinesterase (mAChE).
METHODS: We conducted all-atom steered molecular dynamics simulations of the two protein-drug complexes. Through a host of protein-drug interaction parameters (rupture force profiles, hydrogen bonds, water bridges, hydrophobic interactions), geometrical, and orientation ordering of the drugs, we monitored the enzyme's response during the release of the drugs from its active-site.
RESULTS: The results show the preferential binding of the drugs with the enzyme. The pyridinium ring of HI-6 shows excellent complementary binding with the peripheral anionic site, whereas one of two identical pyridinium rings of Ortho-7 has excellent binding compatibility in the enzyme active-site where it can orchestrate the reactivation process. We found that the active pyridinium ring of HI-6 undergoes a complete turn along the active site axis, directed away from the active-site region during the course of the simulation.
CONCLUSION: Due to excellent cooperative binding of Ortho-7, as rendered by several cation-pi interactions with the active-site gorge of the enzyme, Ortho-7 may be a more efficient reactivator than HI-6. Our work supports the growing body of evidence that the efficacy of the drugs is due to the differential bindings of the oximes with AChE and can aid to the rational design of oxime drugs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20140002      PMCID: PMC4002407          DOI: 10.1038/aps.2009.193

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  51 in total

Review 1.  Therapy for nerve agent poisoning.

Authors:  Jonathan Newmark
Journal:  Arch Neurol       Date:  2004-05

Review 2.  Pyridinium oximes: rationale for their selection as causal antidotes against organophosphate poisonings and current solutions for auto-injectors.

Authors:  Milos P Stojiljković; Milan Jokanović
Journal:  Arh Hig Rada Toksikol       Date:  2006-12       Impact factor: 1.948

3.  Dynamic mechanism of E2020 binding to acetylcholinesterase: a steered molecular dynamics simulation.

Authors:  Chunying Niu; Yechun Xu; Yong Xu; Xiaomin Luo; Wenhu Duan; Israel Silman; Joel L Sussman; Weiliang Zhu; Kaixian Chen; Jianhua Shen; Hualiang Jiang
Journal:  J Phys Chem B       Date:  2005-12-15       Impact factor: 2.991

4.  A steered molecular dynamics method with adaptive direction adjustments.

Authors:  Kun Yang; Xinli Liu; Xicheng Wang; Hualiang Jiang
Journal:  Biochem Biophys Res Commun       Date:  2008-12-30       Impact factor: 3.575

5.  Thermodynamics of hydrogen bonding in hydrophilic and hydrophobic media.

Authors:  David van der Spoel; Paul J van Maaren; Per Larsson; Nicusor Tîmneanu
Journal:  J Phys Chem B       Date:  2006-03-09       Impact factor: 2.991

6.  Respiratory failure in acute organophosphorus pesticide self-poisoning.

Authors:  M Eddleston; F Mohamed; J O J Davies; P Eyer; F Worek; M H R Sheriff; N A Buckley
Journal:  QJM       Date:  2006-07-22

Review 7.  Oximes in acute organophosphorus pesticide poisoning: a systematic review of clinical trials.

Authors:  M Eddleston; L Szinicz; P Eyer; N Buckley
Journal:  QJM       Date:  2002-05

8.  Studying enzyme binding specificity in acetylcholinesterase using a combined molecular dynamics and multiple docking approach.

Authors:  Jeremy Kua; Yingkai Zhang; J Andrew McCammon
Journal:  J Am Chem Soc       Date:  2002-07-17       Impact factor: 15.419

9.  Physostigmine, tacrine and metrifonate: the effect of multiple doses on acetylcholine metabolism in rat brain.

Authors:  M Hallak; E Giacobini
Journal:  Neuropharmacology       Date:  1989-03       Impact factor: 5.250

10.  Targeted synthesis of 1-(4-hydroxyiminomethylpyridinium)-3-pyridiniumpropane dibromide--a new nerve agent reactivator.

Authors:  Kamil Kuca; Kamil Musilek; Martin Paar; Daniel Jun; Petr Stodulka; Martina Hrabinova; Jan Marek
Journal:  Molecules       Date:  2007-08-20       Impact factor: 4.411

View more
  7 in total

1.  Influence of gauche effect on uncharged oxime reactivators for the reactivation of tabun-inhibited AChE: quantum chemical and steered molecular dynamics studies.

Authors:  Shibaji Ghosh; Kalyanashis Jana; Bishwajit Ganguly
Journal:  J Comput Aided Mol Des       Date:  2018-07-06       Impact factor: 3.686

2.  Revealing the importance of linkers in K-series oxime reactivators for tabun-inhibited AChE using quantum chemical, docking and SMD studies.

Authors:  Shibaji Ghosh; Nellore Bhanu Chandar; Kalyanashis Jana; Bishwajit Ganguly
Journal:  J Comput Aided Mol Des       Date:  2017-06-23       Impact factor: 3.686

3.  Functional Analysis and Molecular Docking studies of Medicinal Compounds for AChE and BChE in Alzheimer's Disease and Type 2 Diabetes Mellitus.

Authors:  Dowluru Svgk Kaladhar; Nagendra Sastry Yarla; N Anusha
Journal:  Aging Dis       Date:  2013-06-20       Impact factor: 6.745

4.  Energetics of Ortho-7 (oxime drug) translocation through the active-site gorge of tabun conjugated acetylcholinesterase.

Authors:  Vivek Sinha; Bishwajit Ganguly; Tusar Bandyopadhyay
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

5.  New way of direct nitrogen atom phenylation in quinoline derivatives.

Authors:  Nadezhda E Shchepina; Viktor V Avrorin; Gennady A Badun; Scott B Lewis; Sergey N Shurov
Journal:  ISRN Org Chem       Date:  2012-07-03

Review 6.  Computational Studies on Acetylcholinesterases.

Authors:  Yechun Xu; Shanmei Cheng; Joel L Sussman; Israel Silman; Hualiang Jiang
Journal:  Molecules       Date:  2017-08-10       Impact factor: 4.411

Review 7.  FDA-Approved Oximes and Their Significance in Medicinal Chemistry.

Authors:  Jyothi Dhuguru; Eugene Zviagin; Rachid Skouta
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.